Back to Search Start Over

A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing.

Authors :
Lengyel E
Li Y
Weigert M
Zhu L
Eckart H
Javellana M
Ackroyd S
Xiao J
Olalekan S
Glass D
Iyer S
Krishnan R
Bilecz AJ
Lastra R
Chen M
Basu A
Source :
Cell reports [Cell Rep] 2022 Dec 20; Vol. 41 (12), pp. 111838.
Publication Year :
2022

Abstract

As part of the Human Cell Atlas Initiative, our goal is to generate single-cell transcriptomics (single-cell RNA sequencing [scRNA-seq], 86,708 cells) and regulatory (single-cell assay on transposase accessible chromatin sequencing [scATAC-seq], 59,830 cells) profiles of the normal postmenopausal ovary and fallopian tube (FT). The FT contains 11 major cell types, and the ovary contains 6. The dominating cell type in the FT and ovary is the stromal cell, which expresses aging-associated genes. FT epithelial cells express multiple ovarian cancer risk-associated genes (CCDC170, RND3, TACC2, STK33, and ADGB) and show active communication between fimbrial epithelial cells and ovarian stromal cells. Integrated single-cell transcriptomics and chromatin accessibility data show that the regulatory landscape of the fimbriae is different from other anatomic regions. Cell types with similar gene expression in the FT display transcriptional profiles. These findings allow us to disentangle the cellular makeup of the postmenopausal FT and ovary, advancing our knowledge of gynecologic diseases in menopause.<br />Competing Interests: Declaration of interests E.L. receives research funding to study ovarian cancer from Arsenal Bioscience and AbbVie through the University of Chicago unrelated to this work. A.B. is a consultant for Novartis IBRI.<br /> (Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
2211-1247
Volume :
41
Issue :
12
Database :
MEDLINE
Journal :
Cell reports
Publication Type :
Academic Journal
Accession number :
36543131
Full Text :
https://doi.org/10.1016/j.celrep.2022.111838